摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-Isopropyl-6-(4-methylpiperazinyl)-indole | 321745-05-5

中文名称
——
中文别名
——
英文名称
1-Isopropyl-6-(4-methylpiperazinyl)-indole
英文别名
6-(4-methylpiperazin-1-yl)-1-propan-2-ylindole
1-Isopropyl-6-(4-methylpiperazinyl)-indole化学式
CAS
321745-05-5
化学式
C16H23N3
mdl
——
分子量
257.379
InChiKey
PDFSEDDUVDRICO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    397.0±32.0 °C(Predicted)
  • 密度:
    1.09±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    19
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    11.4
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    2-碘代丙烷6-(4-甲基哌嗪-1-基)-1H-吲哚 在 sodium hydride 、 potassium carbonateN,N-二甲基甲酰胺 作用下, 以 甲苯 为溶剂, 反应 1.0h, 以83%的产率得到1-Isopropyl-6-(4-methylpiperazinyl)-indole
    参考文献:
    名称:
    Heterocyclic compounds for the treatment of migraine
    摘要:
    本文描述了在治疗偏头痛中有用的化合物,其具有以下一般公式:其中:W是一个CH基团或一个N原子;Z是N或C—R4;B和D分别从CH和N中选择,但至少其中一个是CH,并进一步规定其中一个可以表示N,只有当W和Z都不是N时;A是公式II、III或IV的一个基团,使得基团A至少含有1个N原子;NR7要么是—NH—要么是—N═; 是一个单键或双键;X是一个N原子、一个CH基团或一个C(OH)基团,当 是一个单键时;或者,当 是一个双键时,是一个C原子;Y是一个NH、N-烷基、N-苄基或CH2基团;U和V分别代表一个N原子或一个CH基团,但两者不能都是N;a和b分别独立地为0或1;c是一个从0到3的整数;d是一个从1到3的整数;e是一个从1到2的整数;f是一个从0到3的整数;g是一个从3到6的整数,h是一个从2到3的整数;使得c和d的总和至少为2,e和f的总和至少为2;以及它们的盐和溶剂化合物。
    公开号:
    US06716837B1
点击查看最新优质反应信息

文献信息

  • INDOLES AND INDAZOLES FOR THE TREATMENT OF MIGRAINE
    申请人:NPS Allelix Corp.
    公开号:EP1196380A2
    公开(公告)日:2002-04-17
  • US6716837B1
    申请人:——
    公开号:US6716837B1
    公开(公告)日:2004-04-06
  • [EN] HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF MIGRAINE<br/>[FR] COMPOSES HETEROCYCLIQUES DESTINES AU TRAITEMENT DE LA MIGRAINE
    申请人:NPS ALLELIX CORP
    公开号:WO2001005758A2
    公开(公告)日:2001-01-25
    Described herein are compounds useful in the treatment of migraine, which have general formulae (I), (II), (III) and (IV), wherein : W is a CH group or an N atom ;Z is N or C-R4; B and D are selected independently from CH and N, with the proviso that at least one of B and D is CH and with the further proviso that one of B and D can represent N only when W and Z are both other than N; A is a group of Formula (II), (III) or (IV), such that group A contains at least 1 N atom ; NR7 is either -NH- or -N=--- is a single or double bond ; X is an N atom, a CH group or a C(OH) group when --- is a single bond; or, when --- is a double bond, a C atom; Y is an NH, N-alkyl, N-benzyl or CH2 group; U and V each represent an N atom or a CH group, with the proviso that both cannot be N; a and b are, independently, 0 or 1; c is an integer from 0 to 3; d is an integer from 1 to 3; e is an integer from 1 to 2; f is an integer from 0 to 3; g is an integer from 3 to 6 and h is an integer from 2 to 3; such that the sum of c and d is at least 2 and the sum of e and f is at least 2; R1 is selected from the group consisting of H, alkyl, alkyloxy, alkanoyl, aminoalkylenyl, alkylaminoalkylenyl, a hydroxyalkylenyl group, an alkyloxyalkylenyl group, a cycloalkyl group, a cycloalkylalkylenyl group, a heterocycloalkyl group, a heterocycloalkylalkylenyl group, an aryl group, a heterocycloaryl group, an amido group, a thioamido group, an arylcarbonyl group and an arylsulfonyl group; R2 and R3 are independently selected from the group consisting of H, alkyl, cycloalkyl, alkenyl and optionally-substituted benzyl; or R2 and R3, together with the nitrogen atom to which they are attached, may form a mono- or bi-cyclic group containing up to 10 carbon atoms and which, in addition, may contain a second heteroatom selected from the group consisting of N, S and O, and which may contain one or more substituents selected from the group consisting of alkyl, hydroxy, hydroxymethyl, alkyloxymethyl, amino and substituted amino; R4 is selected from the group consisting of H, alkyl and cycloalkyl; CR5 represents a group selected from -CH2-, CH(OH)-, -C(O)-, -CH(alkyl)- and -CH(alkyloxy)-; R6 is selected from the group consisting of H, alkyl, aryl, halogen, hydroxy, alkyloxy, amino, monoalkylamino and di-substituted alkylamino; and salts and solvates thereof.
  • Heterocyclic compounds for the treatment of migraine
    申请人:NPS Allelix Biopharmaceuticals, Inc.
    公开号:US06716837B1
    公开(公告)日:2004-04-06
    Described herein are compounds useful in the treatment of migraine, which have the general formula: wherein: W is a CH group or a N atom; Z is N or C—R4; B and D are selected independently from CH and N, with the proviso that at least one of B and D is CH and with the further proviso that one of B and D can represent N only when W and Z are both other than N; A is a group of Formula II, III or IV, such that group A contains at least 1 N atom; NR7 is either —NH— or —N═; is a single or double bond; X is a N atom, a CH group or a C(OH) group when is a single bond; or, when is a double bond, a C atom; Y is an NH, N-alkyl, N-benzyl or CH2 group; U and V each represent a N atom or a CH group, with the proviso that both cannot be N; a and b are, independently, 0 or 1; c is an integer from 0 to 3; d is an integer from 1 to 3; e is an integer from 1 to 2; f is an integer from 0 to 3; g is an integer from 3 to 6 and h is an integer from 2 to 3; such that the sum of c and d is at least 2 and the sum of e and f is at least 2; and salts and solvates thereof.
    本文描述了在治疗偏头痛中有用的化合物,其具有以下一般公式:其中:W是一个CH基团或一个N原子;Z是N或C—R4;B和D分别从CH和N中选择,但至少其中一个是CH,并进一步规定其中一个可以表示N,只有当W和Z都不是N时;A是公式II、III或IV的一个基团,使得基团A至少含有1个N原子;NR7要么是—NH—要么是—N═; 是一个单键或双键;X是一个N原子、一个CH基团或一个C(OH)基团,当 是一个单键时;或者,当 是一个双键时,是一个C原子;Y是一个NH、N-烷基、N-苄基或CH2基团;U和V分别代表一个N原子或一个CH基团,但两者不能都是N;a和b分别独立地为0或1;c是一个从0到3的整数;d是一个从1到3的整数;e是一个从1到2的整数;f是一个从0到3的整数;g是一个从3到6的整数,h是一个从2到3的整数;使得c和d的总和至少为2,e和f的总和至少为2;以及它们的盐和溶剂化合物。
查看更多